A modified provocative test to assess the safety of embolization of cerebral and spinal arteriovenous malformations is described. The modified test uses successive amobarbital and lidocaine injections to elicit any possible neurological deficit, both mixed with radiopaque material to visualize the distribu tion of the anesthetic in the vessels. The modified provocative test caused no false negative results in 11 patients tested, compared to six of 27 patients with the unmodified method.
Introduction
The provocative test is important in the endovascular treatment of cerebral and spinal arteriovenous malformations (AVMs), but false negative results resulting in the development of neurological deficits are a critical problem. False negative results may oc cur because of a discrepancy in the distributions of the injected embolic material and the anesthetics used to provoke neurological symptoms. The distribution of radiopaque lidocaine has been visualized in testing extracranial arteries2'3) in con junction with fluoroscopic control.
Here, we propose a method of provocative testing using radiopaque amobarbital and lidocaine to en sure any potential neurological deficit is identified, and to provide a digital subtraction angiography (DSA) image for accurate delivery of embolic material.
Methods
The radiopaque amobarbital contained 0.5 ml of 10% amobarbital sodium and 0.5 ml of iopamidol (Iopamiron 300; Schering, Berlin, Germany) mixed just before injection, since the mixture may pre cipitate after 20 minutes. The radiopaque lidocaine mixture contained 0.4 ml of 10% cardiac lidocaine and 1.6 ml of lopamiron 300. The anesthetic mixtures were injected superselec tively using a Tracker catheter (Target Therapeutics Inc., San Jose, Cal., U.S.A.) or a Magic catheter (Balt, Montmorency, France) into the feeding vessels prior to the occlusion. DSA was performed with 1 ml of the amobarbital mixture (50 mg amobarbital). The lumen was then flushed with 1 ml of distilled water. Neurological examination tested for any new deficit elicited by the anesthetic. If positive, occlu sion of that vessel was abandoned. If the amobar bital test was negative, the same procedure was repeated with 2 ml of lidocaine mixture (40 mg lido caine). The provocative test was considered negative only when neither anesthetic provoked a new neurological deficit.
Embolization material was injected carefully to oc clude only those vessels opacified during the pro vocative test. Ethylene vinylalcohol copolymer, a radiopaque liquid embolization material,') was used on most occasions. 
Results
Twenty-six feeding vessels in 11 patients (2 spinal AVMs, 8 cerebral AVMs, and 1 dural arteriovenous fistula) were evaluated with this method. In all patients except one, the distributions of both anesthetic mixtures were identical (Fig. 1) . In one pa tient, a small discrepancy was seen in the distribution (Fig. 2) . DSA clearly visualized the destination of the anesthetics (Fig. 3) . This allowed the embolization to be performed without occluding untested branches. Provocative testing of the 26 feeders resulted in 24 negative and two positive results. The symptoms pro voked were leg monoparesis in a spinal AVM patient (Fig. 3) and hearing disturbance in a cerebellar AVM patient. No neurological deficits occurred during or after the embolization procedure when the test was negative. No convulsions occurred.
Discussion
Our method for provocative testing allows emboliza tion to be performed with more safety and certainty. Radiopaque anesthetics clearly demonstrate the affected vessels and avoid the ambiguity of blind in jection, while careful selection of the vessels for oc clusion is possible. The distribution of embolic material may change during injection as the distal part of the feeding artery is occluded. Radiopaque embolic material flowing into a vessel not visualized during the preceding provocative test can be rapidly identified and injection stopped immediately. Radiopaque anesthetic was particularly effective in spinal AVM to ensure that the anesthetics reached the nidus. Most spinal AVMs have small feeding vessels distant from the nidus which prevent prox imal catheterization. Therefore, blind injection might result in substantial amounts of anesthetics entering the radiculomedullary artery or refluxing to the intercostal artery and aorta before reaching the nidus affecting the provocative test outcome (Fig. 3) . Any distribution discrepancy between the two anesthetic mixtures, although rare in our preliminary study, requires repeat injection or consideration of the distribution difference in judging the result.
The choice of anesthetic is under discussion, although amobarbital is usually used in cerebral AVMs,',') and lidocaine in the extracranial arteries.3) We repeated the provocative test with both anesthetics to assure complete safety for the em bolization.
2) The pharmacological actions of these drugs are different, so negative results in both tests ensure the absence of neurological complications after embolization. In our institute, provocative testing had previously used amobarbital alone. False negative results had occurred in six of 27 cerebral AVM patients (22.2%) resulting in permanent neurological deficits. After these frustrating ex periences, 24 AVMs were tested with amobarbital and lidocaine. The first 13 patients were tested with anesthetics without contrast material, thus testing by blind injection. Two false negatives occurred in these 13 patients (15.4%), but both lead to temporary neurological deficits. The latter 11 patients were tested with radiopaque anesthetic mixtures, and no false negatives occurred (0%). The combination of two anesthetics and radiopaque material both con tribute to reducing the occurrence of false negatives. The test itself caused no complications in our study, although lidocaine injection may cause convulsion.2) The amobarbital injection prior to lidocaine might help prevent such an effect. No electrophysiological monitoring was used in our testing, although this would be helpful in evaluating the result.s,6) Amobarbital was delivered as sodium amobarbital to achieve high water solubility. The solution of sodium amobarbital is alkaline and precipitates at lower pH.') As lidocaine is acid, it is essential to ir rigate the delivery catheter between injections of the two anesthetics. Amobarbital also precipitates in 20 30 minutes after mixing with lopamiron, so the mix ture must be prepared immediately before injection. A mixture of lidocaine and lopamiron has been used in the embolization of hepatoma without any prob The use of two anesthetics with different phar macological action decreased the incidence of false negative results, while visualizing the distribution of the injected drugs avoided the occlusion of untested vessels. These modifications increase the reliability of the provocative test. 
